RxDoctor Payments Data

Pawel Dyk, MD

Radiation Oncology · Saint Louis, MONPI 1578791000

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations.

$1,795in general payments, 2019–2025

Across 90 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$202
  • Bayer$119
  • AbbVie$93
  • Merck$88
  • Lilly USA, LLC$85
  • Johnson & Johnson$77
  • plus $1K from 37 others

What the payments were for

  • Food & beverage$1,78299%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,795 in reported general payments places this provider in the 65th percentile of 123 radiation oncology providers in Missouri.

See all radiation oncology providers in Missouri

Medicare billing

Part B allowed, 2024
$263,294
Medicare patients
377
Services billed
3,095

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium111$1,108
Lidocaine Hcl ViscousLidocaine Hcl29$724
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$379
Memantine Hcl16$258
Dexamethasone12$228
Gabapentin21$190
Nystatin12$190
Morphine Sulfate ErMorphine Sulfate14$183
Tamsulosin Hcl24$155
Oxycodone Hcl14$92
Tramadol Hcl28$62
Lorazepam12$8

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →